Here are seven updates:
ASC News
Fresenius Vascular Care is changing its name to Azura Vascular Care to reflect the company's changes within the last several years.
Surgeons at Boston Out-Patient Surgical Suites in Waltham, Mass., performed the first outpatient total joint replacement at a freestanding ASC in the state.
The FDA approved Becton, Dickinson and Co.'s Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments.
The question over how providers can effectively manage pain has taken on a more prominent role in the media over the last several years as the industry challenges providers to limit opioid use. Working with the AAAHC Institute for Quality…
AmSurg is increasing patient engagement through a clinical data-based platform that encourages participation and compliance.
Life science technology company Sanovas plans to create a venture capital fund and innovation center in the China-based Suzhou Institute of Nanotechnology and NanoBionics.
Self-employed physicians have an average higher compensation than employed physicians, according to Medscape's "Physician Compensation Report 2017."
Through 2022, the global micro-invasive glaucoma surgery market is likely to increase at a 47.1 percent compound annual growth rate.
Growth, value-based care and payer reimbursement are some of the most pressing issues Michael J. Patterson, president and CEO of Davenport, Iowa-based Mississippi Valley Health, believes the ASC industry is facing.
